RFP 2024 Announced

MIT Center for Biomedical Innovation and the Coca-Cola Company announced the next request for proposals (RFP) with an application deadline of May 29th, 2024. The Grand Challenge for Alternatives to Sugar program expects to fund at least two additional projects with this new RFP. For more details, click here. Instructions for MIT DLCs on submitting proposals found here. Grand Challenge…Continue Reading RFP 2024 Announced

CAACB Publishes on NGS

The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) collected historical data from 20 biopharmaceutical industry members on their experience with the in vivo adventitious virus test, the in vitro virus test, and the use of next generation sequencing (NGS) for viral safety. The new publication discusses the risks and challenges of replacing in vivo…Continue Reading CAACB Publishes on NGS

SMART researchers enable early-stage detection of microbial contamination in cell therapy

Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have identified a critical quality attribute that potentially allows the development of a rapid and sensitive process analytical technology for sterility. Specifically, this technology enables the detection of early-stage microbial contamination in human cell therapy products. To learn more, read the…Continue Reading SMART researchers enable early-stage detection of microbial contamination in cell therapy

Applying Nanofluidics to Enhance Biomanufacturing

AZoNano interviews Biomanfacturing@MIT-CBI collaborator Dr. Georgios ‘Yorgos’ Katsikis, a researcher in the laboratory of Scott Manalis, the Andrew (1956) and Erna Viterbi Professor, Professor of Biological and Mechanical Engineering, about his involvement in new research that employs nanofluidics to assess the DNA content of viral vectors, a critical component of gene therapy. Integrating this approach…Continue Reading Applying Nanofluidics to Enhance Biomanufacturing

Biomanufacturing@MIT-CBI Research Published in ‘Biomaterials’.

Biomanufacturing@MIT-CBI researchers provide an in-depth analysis of bioprocess technologies needed for cell-based meat production and challenges in reaching commercial scale. Specifically, it reviews state-of-the-art bioprocess technologies, current limitations, and opportunities for research across four domains: cell line development, cell culture media, scaffolding, and bioreactors. Fore more information, read the complete publication: Large-scale cultured meat production: Trends,…Continue Reading Biomanufacturing@MIT-CBI Research Published in ‘Biomaterials’.